Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 1H-Indazole | HCID 9221 | — |
| Reactant | Potassium Carbonate | HCID 11430 | — |
| Reactant | 1-(Bromomethyl)-4-chlorobenzene | HCID 69329 | — |
| Reactant | 5-(Trifluoromethyl)-1H-indazole | HCID 21409222 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 59148074 | HCID 59148074 | 15% |
| Product | HCID 59148154 | HCID 59148154 | 7.7% |
Reaction Steps
Indazole compounds can be synthesized according to methods disclosed in the literature, e.g. Lukin et al. J. Org. Chem. 2006, 71, 8166-8172 and Souers et al. J. Med. Chem. 2005, 48, 1318-1321. A mixture of 5-(trifluoromethyl)-1H-indazole 3a (0.46 g, 2.5 mmol), K2CO3 (1.04 g, 7.5 mmol) in DMF (8 mL) was stirred at room temperature for 30 min. To the mixture was added p-chlorobenzyl bromide (0.77 g, 3.75 mmol). The resulting mixture was heated at 60° C. for 6 h. After cooling, the mixture was poured into water (30 mL). The precipitate was filtered and washed with water and dried. The crude product was purified by chromatography (hexane/dichloromethane, 1:1 to 1:3) to give 1-(4-chlorobenzyl)-5-(trifluoromethyl)-1H-indazole 3b (120 mg, 15%) and 2-(4-chlorobenzyl)-5-(trifluoromethyl)-2H-indazole 3c (60 mg, 7.7%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09149463B2 |
|---|
| Source dataset | uspto-grants-2015_10 |
|---|
| ORD ID | ord-17cf9d8727524e33a370a40d6842b48a |
|---|
| Source note | uspto-grants-2015_10 |
|---|